VERU Stock Could Face Difficulties If the Culper Research Report Is Your article was successfully shared with the contacts you provided. This drop over the last month or so has torched like 9% of my portfolio, real quick. An immediate avalanche of selling started at the open of the 6th, suggesting that news of the basket trial was a bad thing. Eric Volkman has no position in any of the stocks mentioned. The most trusted brand in stock market news; Fatest intelligence & alerts; Active trader chat rooms; Option trade alerts; Only comprehensive mobile notifications solution Feel like going after another group of asshole short sellers trying to screw over us regular investors? On November 15, 2022, Culper Research published a short report on Treace (the "Culper Report"). Credit Solution Experts Incorporated offers quality business credit building services, which includes an easy step-by-step system designed for helping clients build their business credit effortlessly. Mark Hake writes about personal finance on mrhake.medium.com, Newsbreak.com and Beehiiv.com. Significant to regional and national historical narratives, SBU's letters were authored in 1779 and 1780 and document espionage activities in the Three Village area of Long Island, New York, the . White Diamond Research is a research firm that sells information to hedge funds and high net worth individuals. On Wall Street, H.C. Wainwright dropped Blink Charging to a Neutral rating from Buy last week on a valuation call that did not allude to any wrongdoing at the company..
LifeMD falls after new short call from Culper Research Mohawk Group Holdings) was founded by . The Cable Car website is down right now, but does indicate a connection to an investment partnership with the Funicular Fund. Yes, the two executives were at Redwood Scientific. Verified account Protected Tweets @; Suggested users To the best of our ability and belief, all information contained herein is accurate and reliable, and has been obtained from public sources we believe to be accurate and reliable, and who are not insiders or connected persons of the securities covered herein or who may otherwise owe any fiduciary duty or duty of confidentiality to the issuer.
Hindenburg Research - Investigative Research & Reporting Guys, this is a classic short attack. For instance, Culper Research alleges that LifeMD presents misleading information regarding its network of doctors and even uses unlicensed professionals "to dispense OTC medication.". Town square for LifeMD ($LFMD) stakeholders, Press J to jump to the feed.
Why Veru Stock Plummeted on Monday | The Motley Fool The report seems to imply that Veru will be another failure just like other drug companies the management has run. Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Culper Research alleges that the company appears to use unlicensed doctors to dispense OTC medications. To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. What Is the Best EV Stock to Buy Now? Tickets are limited. I like pain so I'm holding and also bought 400 more shares at $9, sitting at 2,000 shares now with a $16 cost basis, plus August calls with $15 strike that I bought just before market close yesterday. Link to CULPER RESEARCH https://img1.wsimg.com/blobby/go/cc91fda7-4669-. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. In no event should Culper or any affiliated party be liable for any direct or indirect trading losses caused by any information on this site. The rather eclectic biotech -- it has a female contraceptive product, FC2, on the market, and is developing cancer drugs -- has attracted much interest because of the apparently promising sabizabulin. Like, within two days of the report, which just adds to the shadiness of the situation. 2023 InvestorPlace Media, LLC. Investors might want to watch out. quotes delayed at least 15 minutes, all others at least 20 minutes.
CleanSpark Investigating Short Seller Culper Research | Nasdaq This implies that it could end up wasting a lot of its cash if the Phase 3 clinical study is not successful in obtaining FDA EUA approval. For example, on April 11 Veru announced its Covid-19 drug brought down the mortality rate by 55% but the Culper report said that this was a manipulation of how high mortality rates were with Covid-19. Terms of Service.
Home - George Washington and the Culper Spy Ring - Research & Subject Thank you for your interest in the U.S. Securities and Exchange Commission. At just 150 patients, the trial is a . Agreed, this is pretty shitty but have to wait for the response. LFMD responded to short report, denying the claims and will report something in detail soon. The company generated about $23,100 in revenue for the first half of 2021. I have not but wouldn't it stand to reason that a smaller company entering the space would need to spend more to build brand awareness? Cost basis and return based on previous market day close. I do wish to raise two issues: Rivington and my background.
For example, if it has to redesign the study and start from scratch the costs could go up. Has anyone attempted to recalculate their marketing cost per website visitor for LFMD vs HIMS. On December 3, 2020, Culper tweeted regarding a FOIA request for information from SEC on any investigations into a company called CytoDyn $CYDY. Customer Service| But that attitude raises a few questions.
Law Firm Investigating Bitcoin Miner Core Scientific for Alleged What Joseph L. Rini Knows, Attorney Rachel Y. Marshall A Pillar of Strength for the Community, SpotDraft Raises $26 Million in Series A Funding for AI-Powered Legal Software. By accepting all cookies, you agree to our use of cookies to deliver and maintain our services and site, improve the quality of Reddit, personalize Reddit content and advertising, and measure the effectiveness of advertising. The Company also owns and operates a fleet of over 3,400 ASIC (application-specific integrated circuit) Bitcoin miners producing over 200 PH/s in mining capacity. When typing in this field, a list of search results will appear and be automatically updated as you type. To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. CleanSpark, Inc., a Nevada corporation, is in the business of providing advanced software and controls technology solutions to solve modern energy challenges. We have a suite of software solutions that provide end-to-end microgrid energy modeling, energy market communications, and energy management solutions. Skip to Main Content.
SOS Stock: Is it Buy the Bounce or Run Like Hell? Use of Culper Research's ("Culper") research is at your own risk. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
SEC.gov | HOME 2) In April, $VERU announced Phase III results (without full data) of sabizabulin (VERU-111) in hospitalized COVID-19 patients. 1001 and 1030). Will Aterian stock recover from this short attack? The apparent purpose of the Culper Research "report" is to cover or profit from the publisher's short positions in the Company, which the publisher expressly acknowledges holding in the report itself. A recent report by Culper Research contains numerous false and misleading statements about our company. https://www.google.com/amp/s/seekingalpha.com/amp/news/3681732-lifemd-falls-after-new-short-call-from-culper-research. Not really sure how to end this post, but please let me know think. Veru has a market capitalization of $750 million at $8.46 as of May 6. However, such information is presented as is, without warranty of any kind whether express or implied. If You Invested $1,000 in Veru in 2020, This Is How Much You Would Have Today, 2 Reasons to Avoid a Roth 401(k) for Your Retirement Savings, Want $1 Million in Retirement? Although we identified the historical legal concerns raised in the report, they were unrelated to the acquired businesses. Veru has a market capitalization of $750 million at $8.46 as of May 6. Theyre calculating that LFMD spends an average of $36 in marketing costs per webpage visitor for REXMD while HIMS spends an average of $2.14 per website visitor for its products . Culper also . Another bright side is the short report does not have a single mention of PDFSimpli, so if all else fails and the telehealth biz goes to zero at least we have a market cap base of maybe $60-70 million for PDFSimpli lol. Is this happening to you frequently? Culper research countered with a well-timed short report tweeted at 8:05 AM spreading fear in the minds of longs that something was wrong going into the investor call. By using this site, you are agreeing to security monitoring and auditing. Further, Culper Research thinks LifeMD is engaged in fraudulent and illegal activities that are similar to those of Redwood Scientific, a company that faced severe legal penalties at the hands of . Were short sellers putting together a scam? To hide from slander cases, perhaps?).
The Great CytoDyn (OTCQB: CYDY) Bear Raid Fails to Impress The report points out two major issues: first, the Phase 3 Covid-19 study contains glaring issues, compounded by management misrepresentations.. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. Yes, it works for cancers, but it does the same to all normal tissue.
Dissecting the Xometry Stock Short Report - Nanalyze